ADC Therapeutics SA (ADCT) — Capital Reinvestment Ratio

Latest as of September 2022: 0.12x

ADC Therapeutics SA (ADCT) has a Capital Reinvestment Ratio of 0.12x as of September 2022, meaning it reinvests 0% of its operating cash flow ($2.19 Million) in capital expenditures ($254.00K). See net asset quality index of ADC Therapeutics SA to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.12x

Capex / Operating Cash Flow

Operating Cash Flow

$2.19 Million

USD

Capital Expenditures

$254.00K

USD

Data as of

Sep 2022

Most recent filing

Annual Capital Reinvestment Ratio for ADC Therapeutics SA (None–None)

Year-by-year Capital Reinvestment Ratio for ADC Therapeutics SA from None to None. For live market cap and broader valuation context, see market cap of ADC Therapeutics SA.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow